Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inductive vs Adjuvant Chemoradiation for High-risk NPC
NCT01797900Phase 2Completed
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Mar 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, paclitaxel in nasopharyngeal carcinoma (NPC), sponsored by Chinese Academy of Medical Sciences. Started Mar 2013; status: completed.
02
Drugs
cisplatinpaclitaxel
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT01797900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01797900.